Latest Form 4 insider transactions

Maricel Apuli, Chief Accounting Officer of BridgeBio Pharma, Inc., reported a transaction in 4,714 shares of common stock on August 16, 2026.

James Nelson Pepin, Gen Counsel and Corp Secretary of Immatics N.V., reported multiple transactions in common stock on August 14, 2026.

Andrew Enrietti, See Remarks of Viatris Inc, reported multiple transactions in common stock on August 15, 2026.

Darren Graeler, Chief Accounting Officer of loanDepot, Inc., reported multiple transactions in common stock on August 17, 2026.

Christopher M. Capozzi, Chief Financial Officer of Ethos Technologies Inc., sold 26,184 shares of common stock on August 17, 2026.

Peter George Colis, CEO and Secretary and a Director of Ethos Technologies Inc., sold 29,342 shares of common stock on August 17, 2026.

Lingke Wang, President and a Director of Ethos Technologies Inc., sold 22,623 shares of common stock on August 17, 2026.

Brandt Walter Kucharski, Chief Accounting Officer of Ethos Technologies Inc., sold 83,047 shares of common stock on August 14, 2026.

William George Iii, CHIEF FINANCIAL OFFICER of Comfort Systems Usa Inc, sold 2,554 shares of common stock on August 17, 2026 for $1,859.65 per share.

Shanti B. Gupta, Chief Operating Officer of AST SpaceMobile, Inc., reported a transaction in 12,767 shares of common stock on August 15, 2026.

Andrew Martin Johnson, CFO and CLO and a Director of AST SpaceMobile, Inc., reported multiple transactions in common stock on August 15, 2026.

Maya Bernal, Chief Accounting Officer of AST SpaceMobile, Inc., reported a transaction in 2,919 shares of common stock on August 15, 2026.

Scott Wisniewski, President of AST SpaceMobile, Inc., reported multiple transactions in common stock on August 15, 2026.

Ronald J Glahn, SVP, Global Sales, Broadband of Harmonic Inc, reported multiple transactions in common stock on August 15, 2026.

Jonathan S Beatty, MD, Head of Advisor Services of Schwab Charles Corp, sold 1,000 shares of common stock on August 17, 2026 for $111.33 per share.

Scott C Neils, CFO and Assistant Secretary of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Kevin Hillesland, SVP, Structured Finance of Gatx Corp, reported a transaction in 70 shares of common stock on August 15, 2026.

Jason Lettmann, CHIEF EXECUTIVE OFFICER and a Director of Alx Oncology Holdings Inc, sold 2,230 shares of common stock on August 17, 2026 for $1.93 per share.

Mauad Bruno Sousa, a Director of Aura Minerals Inc., purchased 11,000 shares of common stock on August 17, 2026 for $78.93 per share.

Shelly Wong, SVP, FINANCE AND CAO of Alx Oncology Holdings Inc, sold 573 shares of common stock on August 17, 2026 for $1.93 per share.

Gregory Wong, CFO of Quinstreet, Inc, sold 11,704 shares of common stock on August 18, 2026 for $20.44 per share.

Alexandros Aldous, General Counsel of Chefs' Warehouse, Inc., sold 35,000 shares of common stock on August 14, 2026.

Asmau Ahmed, a Director of Quinstreet, Inc, sold 25,000 shares of common stock on August 14, 2026.

Sean E Browne, President and CEO and a Director of Xtant Medical Holdings, Inc., reported multiple transactions in common stock on August 15, 2026.

Christina Polychroni, Chief Human Resources Officer of Chefs' Warehouse, Inc., sold 2,752 shares of common stock on August 14, 2026 for $112.00 per share.

Timothy Gertsch, Chief Accounting Officer of agilon health, inc., reported a transaction in 17 shares of common stock on August 16, 2026.

Najat Khan, CEO and President and a Director of Recursion Pharmaceuticals, Inc., reported a transaction in 80,498 shares of common stock on August 17, 2026.

David Hallett, Chief Scientific Officer of Recursion Pharmaceuticals, Inc., reported a transaction in 26,657 shares of common stock on August 17, 2026.

Ben R Taylor, Chief Financial Officer of Recursion Pharmaceuticals, Inc., reported a transaction in 25,018 shares of common stock on August 17, 2026.

Susan M. Canning, SVP, CLO, Corporate Secretary of Hayward Holdings, Inc., sold 3,500 shares of common stock on August 17, 2026 for $15.06 per share.